Our innovative research receives support from public and private funding sources that recognize the high-value impact of our work.
Zackary Falls, PhD
A translational bioinformatics approach to elucidate and mitigate polypharmacy induced adverse drug reactions. Zackary Falls (Principal Investigator). National Institute on Drug Abuse. $1,046,435. 7/1/2022-6/1/2027.
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education. Zackary Falls (Co-Investigator). National Library of Medicine. $667,598. 9/1/2022-8/1/2027.
High-performance Computing Drug Discovery Initiative. Zackary Falls (Co-Investigator). National Institute of Standards and Technology (NIST). $1,000,000. 11/1/2022-10/1/2023.
Buffalo Clinical and Translational Research Center Clinical and Translational Science Award (CTSA). Ram Samudrala (Co-Investigator). National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health. $20,178,410. 12/1/2019-12/1/2024.